Recombinant multi-species SMARCA4/BRG1/BAF190A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SMARCA4/BRG1/BAF190A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
The Alternative Names of target: ATP-dependent helicase SMARCA4,BAF190,BAF190A,BRG1,BRG1-associated factor 190A (BAF190A),Brg1,CSS4,HP1-BP72,MRD16,Mitotic growth and transcription activator,OTSC12,Protein BRG-1,Protein brahma homolog 1,RTPS2,SMARCA4,SNF2,SNF2-beta,SNF2L4,SNF2LB,SNF2beta,SW1/SNF,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4,SWI2,Smarca4,Transcription activator BRG1,b2b508.1Clo,b2b692Clo,brg-1,hSNF2b
Go
to SMARCA4/BRG1/BAF190A products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T69200-Ag-1/ GM-Tg-hg-T69200-Ag-2 | Human SMARCA4/BRG1/BAF190A protein | Human |
| GM-Tg-rg-T69200-Ag-1/ GM-Tg-rg-T69200-Ag-2 | Rat SMARCA4/BRG1/BAF190A protein | Rat |
| GM-Tg-mg-T69200-Ag-1/ GM-Tg-mg-T69200-Ag-2 | Mouse SMARCA4/BRG1/BAF190A protein | Mouse |
| GM-Tg-cynog-T69200-Ag-1/ GM-Tg-cynog-T69200-Ag-2 | Cynomolgus/Rhesus macaque SMARCA4/BRG1/BAF190A protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T69200-Ag-1/ GM-Tg-felg-T69200-Ag-2 | Feline SMARCA4/BRG1/BAF190A protein | Feline |
| GM-Tg-cang-T69200-Ag-1/ GM-Tg-cang-T69200-Ag-2 | Canine SMARCA4/BRG1/BAF190A protein | Canine |
| GM-Tg-bovg-T69200-Ag-1/ GM-Tg-bovg-T69200-Ag-2 | Bovine SMARCA4/BRG1/BAF190A protein | Bovine |
| GM-Tg-equg-T69200-Ag-1/ GM-Tg-equg-T69200-Ag-2 | Equine SMARCA4/BRG1/BAF190A protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T69200-Ag-1/ GM-Tg-hg-T69200-Ag-2;
GM-Tg-rg-T69200-Ag-1/ GM-Tg-rg-T69200-Ag-2;
GM-Tg-mg-T69200-Ag-1/ GM-Tg-mg-T69200-Ag-2; GM-Tg-cynog-T69200-Ag-1/ GM-Tg-cynog-T69200-Ag-2; GM-Tg-felg-T69200-Ag-1/ GM-Tg-felg-T69200-Ag-2; GM-Tg-cang-T69200-Ag-1/ GM-Tg-cang-T69200-Ag-2; GM-Tg-bovg-T69200-Ag-1/ GM-Tg-bovg-T69200-Ag-2; GM-Tg-equg-T69200-Ag-1/ GM-Tg-equg-T69200-Ag-2 |
| Products Name | SMARCA4/BRG1/BAF190A protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | SMARCA4/BRG1/BAF190A |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SMARCA4/BRG1/BAF190A protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.